SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Agouron Pharmaceuticals (AGPH)
An SI Board Since March 1996
Posts SubjectMarks Bans Symbol
6136 24 0 AGPH
Emcee:  Bhag Karamchandani Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
4986 When's the next big industry meet? I must say the stock has held welSteve Fancy-7/24/1998
4985 I don't see any opportunity for those who are short to cover, from this poiscaram(o)uche-7/24/1998
4984 Izzy, LGND's pipeline should be attractive to many, but I really don't Henry Niman-7/24/1998
4983 Nate, I doubt they overpaid for any of the three inlicensed products. I'Peter Singleton-7/24/1998
4982 Overpaid? Perhaps. But hopefully the AGPH scientists saw something in the presam-7/24/1998
4981 It seems to me that it is possible that Agouron overpaid on two of the three reNate G-7/24/1998
4980 Henry, enjoyed reading the WSJ MRK article and the favorable information on theIzzy-7/24/1998
4979 Today's WSJ has an extensive article on MRK, including merger speculation. Henry Niman-7/24/1998
4978 Perhaps knowing what Peter Johnson actually said in Agouron's conference cmargie-7/24/1998
4977 >>I worry about whether Peter Johnson is focusing too much on the stock pschadenfreude-7/23/1998
4976 interesting article from bloomberg Ever-New Drug Cocktails for Containing AIDSDoug Heuring-7/23/1998
4975 Bill, I like it too. Let's see what happens in the next few wks and, if thiIzzy-7/23/1998
4974 Izzy: ( Your theory ) Could be a very good one. Peter Johnson has always wanbillkirn-7/23/1998
4973 Joe, my point about judgement was about the judgement of individuals on SI, andPeter Singleton-7/23/1998
4972 I find the discussions of interest. But, a couple of months ago, I presented ascaram(o)uche-7/23/1998
4971 I have read on these threads that the shorts are pointing to high inventory as Zirdu-7/23/1998
4970 "Food for thought" (my theory): What if the company is being split inIzzy-7/23/1998
4969 Joe, Your points are valid. Normally, when management starts to whine about beBiomaven-7/23/1998
4968 Maybe the investor relations dept is run by an amateur!George T. Santamaria-7/23/1998
4967 Seems to me that something less ineffable than judgement is trading costs. UJoe E.-7/23/1998
4966 oh. just to clarify the comment I made to Bhag. There's no one on this thPeter Singleton-7/23/1998
4965 Peter, While I'm flattered to be included in such illustrious company, theBiomaven-7/23/1998
4964 Hey guys, don't forget me...you're favorite AGPH fan (PW report beloSteve Fancy-7/23/1998
4963 Tracking stocks. Biotech analysts fall Vector1-7/23/1998
4962 Aww, shucks, Peter. I appreciate your work, and Rick's, and Vector1's John Metcalf-7/23/1998
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News